Article

Low doses of alcohol substantially decrease glucose metabolism in the human brain.

National Institute on Drug Abuse, 6001 Executive Blvd., Room 5274, Bethesda, MD 20892, USA.
NeuroImage (Impact Factor: 6.13). 02/2006; 29(1):295-301. DOI: 10.1016/j.neuroimage.2005.07.004
Source: PubMed

ABSTRACT Moderate doses of alcohol decrease glucose metabolism in the human brain, which has been interpreted to reflect alcohol-induced decreases in brain activity. Here, we measure the effects of two relatively low doses of alcohol (0.25 g/kg and 0.5 g/kg, or 5 to 10 mM in total body H2O) on glucose metabolism in the human brain. Twenty healthy control subjects were tested using positron emission tomography (PET) and FDG after placebo and after acute oral administration of either 0.25 g/kg, or 0.5 g/kg of alcohol, administered over 40 min. Both doses of alcohol significantly decreased whole-brain glucose metabolism (10% and 23% respectively). The responses differed between doses; whereas the 0.25 g/kg dose predominantly reduced metabolism in cortical regions, the 0.5 g/kg dose reduced metabolism in cortical as well as subcortical regions (i.e. cerebellum, mesencephalon, basal ganglia and thalamus). These doses of alcohol did not significantly change the scores in cognitive performance, which contrasts with our previous results showing that a 13% reduction in brain metabolism by lorazepam was associated with significant impairment in performance on the same battery of cognitive tests. This seemingly paradoxical finding raises the possibility that the large brain metabolic decrements during alcohol intoxication could reflect a shift in the substrate for energy utilization, particularly in light of new evidence that blood-borne acetate, which is markedly increased during intoxication, is a substrate for energy production by the brain.

Full-text

Available from: George Kunos, May 30, 2015
2 Followers
 · 
111 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: During alcohol intoxication, the human brain increases metabolism of acetate and decreases metabolism of glucose as energy substrate. Here we hypothesized that chronic heavy drinking facilitates this energy substrate shift both for baseline and stimulation conditions. To test this hypothesis, we compared the effects of alcohol intoxication (0.75 g/kg alcohol vs placebo) on brain glucose metabolism during video stimulation (VS) versus when given with no stimulation (NS), in 25 heavy drinkers (HDs) and 23 healthy controls, each of whom underwent four PET-(18)FDG scans. We showed that resting whole-brain glucose metabolism (placebo-NS) was lower in HD than controls (13%, p = 0.04); that alcohol (compared with placebo) decreased metabolism more in HD (20 ± 13%) than controls (9 ± 11%, p = 0.005) and in proportion to daily alcohol consumption (r = 0.36, p = 0.01) but found that alcohol did not reduce the metabolic increases in visual cortex from VS in either group. Instead, VS reduced alcohol-induced decreases in whole-brain glucose metabolism (10 ± 12%) compared with NS in both groups (15 ± 13%, p = 0.04), consistent with stimulation-related glucose metabolism enhancement. These findings corroborate our hypothesis that heavy alcohol consumption facilitates use of alternative energy substrates (i.e., acetate) for resting activity during intoxication, which might persist through early sobriety, but indicate that glucose is still favored as energy substrate during brain stimulation. Our findings are consistent with reduced reliance on glucose as the main energy substrate for resting brain metabolism during intoxication (presumably shifting to acetate or other ketones) and a priming of this shift in HDs, which might make them vulnerable to energy deficits during withdrawal. Copyright © 2015 the authors 0270-6474/15/353248-08$15.00/0.
    The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 02/2015; 35(7):3248-55. DOI:10.1523/JNEUROSCI.4877-14.2015 · 6.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 'Omics'-techniques are widely used to identify novel mechanism underlying brain function and pathology. Here we applied a novel metabolomics approach to further ascertain the role of fronto-striatal brain regions for the expression of addiction-like behaviors in rat models of alcoholism. Rats were made dependent via chronic intermittent alcohol vapor exposure. Following a three-week abstinence period rats had continuous access to alcohol in a two-bottle, free-choice paradigm for seven weeks. Non-targeted flow injection time-of-flight mass spectroscopy was used to assess global metabolic profiles of two cortical (prelimbic, infralimbic) and two striatal (accumbens core and shell) brain regions. Alcohol consumption produces pronounced global effects on neurometabolomic profiles leading to a clear separation of metabolic phenotypes between treatment groups, particularly. When further comparing regional tissue levels of various metabolites, most notably dopamine and Met-enkephalin, allow the extrapolation of alcohol consumption history. Finally, a high-drinking metabolic fingerprint was identified indicating a distinct alteration of central energy metabolism in the accumbens shell of excessively drinking rats that could indicate a so far unrecognized pathophysiological mechanism in alcohol addiction. In conclusion, global metabolic profiling from distinct brain regions by mass spectrometry identifies profiles reflective of an animal's drinking history and provides a versatile tool to further investigate pathophysiological mechanisms in alcohol dependence.Neuropsychopharmacology accepted article preview online, 24 November 2014. doi:10.1038/npp.2014.312.
    Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 11/2014; 40(5). DOI:10.1038/npp.2014.312 · 7.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Brain 18F-FDG PET allows the in vivo study of cerebral glucose metabolism, reflecting neuronal and synaptic activity. 18F-FDG PET has been extensively used to detect metabolic alterations in several neurological diseases vs. normal aging. However, healthy subjects exhibit variants of 18F-FDG distribution, especially as associated with aging. 18F-FDG uptake is usually homogeneous and symmetrical, but areas of slightly higher activity are observed in basal ganglia, frontal eye fields, posterior cingulate cortex and visual cortex. On the contrary, relatively lower metabolic activity is observed in medial temporal cortex. This review will focus on 18F-FDG PET findings in so-called normal brain aging, and in particular on metabolic differences occurring with aging and as a function of people's gender. The effect of different substances, medications and therapy procedures will be discussed, as well as common artifacts.
    PET Clinics 04/2014; 9(2):129-140. DOI:10.1016/j.cpet.2013.10.006